tiprankstipranks
Trending News
More News >
Medexus Pharmaceuticals Inc (TSE:MDP)
TSX:MDP
Canadian Market

Medexus Pharmaceuticals Inc (MDP) Income Statement

Compare
67 Followers

Medexus Pharmaceuticals Inc Income Statement

Last quarter (Q2 2026), Medexus Pharmaceuticals Inc's total revenue was C$24.74M, a decrease of -5.94% from the same quarter last year. In Q2, Medexus Pharmaceuticals Inc's net income was C$-315.00K. See Medexus Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 108.33MC$ 113.05MC$ 108.10MC$ 76.70MC$ 79.66M
Gross Profit
C$ 56.58MC$ 59.51MC$ 60.04MC$ 37.93MC$ 42.01M
Operating Expenses
C$ 48.36MC$ 48.72MC$ 52.42MC$ 52.92MC$ 41.27M
Depreciation and Amortization
C$ 7.18MC$ 5.81MC$ 8.05MC$ 7.40MC$ 7.90M
EBITDA
C$ 16.81MC$ 19.28MC$ 16.14MC$ 15.16MC$ -23.61M
Operating Income
C$ 8.22MC$ 10.79MC$ 7.61MC$ -15.00MC$ -1.38M
Other Income/Expenses
C$ -6.78MC$ -10.69MC$ -12.65MC$ 11.18MC$ -30.13M
Pretax Income
C$ 1.44MC$ 106.00KC$ -5.04MC$ -3.82MC$ -31.50M
Net Income
C$ 2.25MC$ -214.00KC$ 1.22MC$ -2.88MC$ -28.26M
Per Share Metrics
Basic EPS
C$ 0.09C$ -0.01C$ 0.08C$ -0.19C$ -2.34
Diluted EPS
C$ 0.08C$ -0.01C$ 0.08C$ -0.19C$ -2.34
Weighted Average Shares Outstanding
25.82M 22.32M 19.98M 19.45M 15.20M
Weighted Average Shares Outstanding (Diluted)
26.51M 22.49M 20.52M 19.86M 15.20M
Currency in CAD

Medexus Pharmaceuticals Inc Earnings and Revenue History